BioSuppress is a synthetic peptide of approximately 39 amino acids in length, possessing a linear structure. It functions as a dual receptor agonist that targets the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) pathways.
This unique design of the peptide allows for protection against rapid degradation via DPP-4 mediated enzymatic cleavage, high bioavailability, and an extended biological half-life for less frequent administration in research settings. Notably, the GIP receptor agonism is believed to counteract the emetic effects known to arrive from GLP-1 receptor agonism in preclinical models.
Peptide Information:
| Peptide Sequence | YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813 g/mol |
| CAS Number | 2023788-19-2 |
| PubChem CID | 156588324 |
| Synonyms | LY3298176 |
Lyophilized Peptides:
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
